Kaminari Medical Logo - medical devices

Kaminari Medical

medical devices
China's Best One-Stop Medical Equipment Provider
About

PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health impairing re-catheterizations In 2015, Coronary Artery Disease (CAD) affected 110 million people and resulted in 8.9 million deaths worldwide. CAD occurs when the arteries that supply the heart muscle with blood become hardened and narrowed, due to the buildup of cholesterol and plaque on their inner walls. Current treatment: To open the blocked coronary arteries, 80% of the patients are treated using a Percutaneous Coronary Intervention (PCI). - Of those patients treated with PCI, 12% get a re-catheterization within 12 months after the initial procedure. - Total costs for these re-catheterizations are estimated at $ 3,5 billion. 50% of these re-catheterizations are caused by a type of stenosis called vulnerable plaques, that are formed by fat-filled cells with a thin cover. If the cover ruptures a blood clot is formed, blocking the coronary artery. - If these vulnerable plaques were treated in an early stage, repeat catheterizations could be prevented. SOLUTION Kaminari combines ultrasound (IVUS) and photoacoustic (PA) imaging, providing better information on both plaque location and composition. Visit our website for more details.

Technologies
Cloudflare DNS MailJet Outlook Microsoft Office 365 CloudFlare Hosting Nginx WordPress.org Mobile Friendly Google Font API Wordpress.com Google Tag Manager AI
Keywords
medical equipment and supplies manufacturing clinical evidence advanced intravascular imaging photoacoustic imaging clinical translation of imaging tech cardiovascular imaging vascular intervention optical technology medical device development signal processing diagnostic technology real-time plaque assessment cardiovascular technology risk assessment medical devices risk management optical imaging catheter-based system regulatory approval healthcare technology innovation vascular diagnostics medical imaging research intravascular imaging platform real-time imaging b2b market entry coronary artery disease plaque characterization photoacoustic intravascular imaging healthtech
Company Information
  • Employees 8
  • Founded 2020
Location

Doctor Molewaterplein, Rotterdam, Zuid-Holland, Netherlands, 3015 GD

Related Companies
Companies in the same industry